Vestal Point Capital’s Astria Therapeutics ATXS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $24.2M | Buy |
4,522,000
+342,000
| +8% | +$1.83M | 1.28% | 30 |
|
|
2025
Q1 | $22.3M | Hold |
4,180,000
| – | – | 1.59% | 22 |
|
|
2024
Q4 | $37.4M | Buy |
4,180,000
+180,000
| +5% | +$1.61M | 2.22% | 16 |
|
|
2024
Q3 | $44M | Buy |
4,000,000
+750,000
| +23% | +$8.26M | 3.34% | 8 |
|
|
2024
Q2 | $29.6M | Buy |
3,250,000
+2,150,000
| +195% | +$19.6M | 2.21% | 13 |
|
|
2024
Q1 | $15.5M | Buy |
+1,100,000
| New | +$15.5M | 1.28% | 19 |
|